Principal Investigator
Aman Chauhan
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20230337
Clinical Trial Summary
Phase II Randomized Control Trial of Triapine Plus Lutetium Lu 177 Dotatate Versus Lutetium Lu 177 Dotatate Alone for Well-Differentiated
Somatostatin Receptor-Positive Neuroendocrine Tumors
Phase
Phase II
Funding Agency/Sponsor
National Cooperative Group
Disease
Stomach and Esophageal Cancer
Contact Information
Phone Number
305-243-2647